Understanding NSCLC Treatments for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Learn more about lung cancer at www.YouAndLungCancer.com
This animation provides an overview of treatments for less common mutations in non-small cell lung cancer (NSCLC): ALK, BRAF, ROS1, HER2, and MET. The good news is that specific treatments can target these mutations. Watch to learn about different targeted therapy treatment options, common side effects, the importance of clinical trials, and more.

[@ellypark48]

my husband has ROS1 so he started to take a medication from 2weeks ago. It is very helpful to me. Thank you!

[@YoungLungCancer]

Thank you. Will share this with our young lung cancer community.